COLESTID Drug Patent Profile
✉ Email this page to a colleague
When do Colestid patents expire, and what generic alternatives are available?
Colestid is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Colestid
A generic version of COLESTID was approved as colestipol hydrochloride by IMPAX LABS on May 2nd, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COLESTID?
- What are the global sales for COLESTID?
- What is Average Wholesale Price for COLESTID?
Summary for COLESTID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Clinical Trials: | 1 |
Patent Applications: | 332 |
Drug Prices: | Drug price information for COLESTID |
What excipients (inactive ingredients) are in COLESTID? | COLESTID excipients list |
DailyMed Link: | COLESTID at DailyMed |
Recent Clinical Trials for COLESTID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
University of Washington | Phase 3 |
Pharmacology for COLESTID
Drug Class | Bile Acid Sequestrant |
Mechanism of Action | Bile-acid Binding Activity |
US Patents and Regulatory Information for COLESTID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | COLESTID | colestipol hydrochloride | GRANULE;ORAL | 017563-003 | Sep 22, 1995 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | COLESTID | colestipol hydrochloride | GRANULE;ORAL | 017563-004 | Sep 22, 1995 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | COLESTID | colestipol hydrochloride | TABLET;ORAL | 020222-001 | Jul 19, 1994 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COLESTID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | COLESTID | colestipol hydrochloride | TABLET;ORAL | 020222-001 | Jul 19, 1994 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COLESTID
See the table below for patents covering COLESTID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0592594 | COMPRIMES A HAUTE TENEUR EN CHLORHYDRATE DE COLESTIPOL (COLESTIPOL HYDROCHLORIDE HIGH-CONTENT TABLETS) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9300915 | ⤷ Sign Up | |
Slovakia | 281920 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |